Back to shop
Thymosin Alpha-1 - 10mg
Healing & Immunity

Thymosin Alpha-1 - 10mg

10mg / Lyophilized *MUST BE RECONSTITUTED* Introducing Thymosin Alpha-1 – a potential immune system ally. Also known as Thymosin Alpha, TA1,

$150

10mg / Lyophilized *MUST BE RECONSTITUTED* Introducing Thymosin Alpha-1 – a potential immune system ally. Also known as Thymosin Alpha, TA1, or T α 1, this fragment of a protein molecule is extensively researched for its role in enhancing immune functions. Derived from Thymosin Fraction 5, it’s a naturally occurring polypeptide with a synthetic counterpart called Thymalfasin. Thymosin Alpha-1 is believed to elevate major histocompatibility complex (MHC) class I, increase cytokine production, and enhance immune responses. Researchers suggest it targets T-helper and cytotoxic T-cell populations, induces cell differentiation, boosts natural killer cell production, stimulates inflammation, and modulates macrophage efficiency and thrombin activity.

Important Research Notice

Research use only. Not for human consumption. This product is intended solely for laboratory research and educational applications. It is not designed for use in the diagnosis, treatment, cure, or prevention of any disease or medical condition. By purchasing this product, you acknowledge that this product is intended for research use only and agree to use it in accordance with all applicable laws and regulations.

References

  1. Thymosin Alpha-1 - 10mg - Peptide Center guide
  2. Thymosin alpha-1American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacist, 2001
  3. Aging and Thymosin Alpha-1International journal of molecular sciences, 2025
  4. The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trialBMJ (Clinical research ed.), 2025
  5. Thymosin alpha-1 treatment in chronic hepatitis BExpert opinion on biological therapy, 2015
  6. Clinical applications of thymosin alpha-1Cancer investigation, 1994
  7. A Pilot Trial of Thymalfasin (Thymosin-α-1) to Treat Hospitalized Patients With Hypoxemia and Lymphocytopenia Due to Coronavirus Disease 2019 InfectionThe Journal of infectious diseases, 2023